公开(公告)号：US20190300479A1

公开(公告)日：2019-10-03

申请号：US16317269

申请日：2017-07-13

Applicant: Conopco, Inc., d/b/a UNILEVER

Inventor： Neil James Parry ,  Paolo Pantalone ,  Paul Williams

IPC: C07D207/44 ,  C07D207/333 ,  A61K9/00 ,  A61K31/402 ,  A61K31/4015 ,  A61P31/04 ,  A61P11/00

Abstract: Lactams for use in the treatment of respiratory tract infections, including chronic lung infections in patients having cystic fibrosis.

公开(公告)号：US20190240196A1

公开(公告)日：2019-08-08

申请号：US16316952

申请日：2017-07-13

Applicant: Conopco, Inc., d/b/a UNILEVER

Inventor： Neil James Parry ,  Paolo Pantalone ,  Paul Williams

IPC: A61K31/4015 ,  A61P17/02 ,  A61P31/04 ,  A61K9/06

CPC classification number: A61K31/4015 ,  A61K9/06 ,  A61K31/40 ,  A61K31/402 ,  A61P17/02 ,  A61P31/04

Abstract: Lactams for use in the treatment of skin lesions are described. In particular, lactams for the treatment of chronic wounds, including chronic wounds in patients having diabetes.

公开(公告)号：US11160787B2

公开(公告)日：2021-11-02

申请号：US16316910

申请日：2017-07-13

Applicant: Conopco, Inc.

Inventor： Neil James Parry ,  Paolo Pantalone ,  Paul Williams

IPC: A61K31/4015 ,  A61P31/04

Abstract: 4-(4-Chlorophenyl)-5-methylene-pyrrol-2-one and 5-methylene-4-(p-tolyl)pyrrol-2-one for use in the treatment of gram-negative bacterial infections, in particular infections in which Pseudomonas is implicated.

公开(公告)号：US20200179338A1

公开(公告)日：2020-06-11

申请号：US16316910

申请日：2017-07-13

Applicant: Conopco, Inc., d/b/a UNILEVER

Inventor： Neil James Parry ,  Paolo Pantalone ,  Paul Williams

IPC: A61K31/4015 ,  A61P31/04

Abstract: 4-(4-Chlorophenyl)-5-methylene-pyrrol-2-one and 5-methylene-4-(p-tolyl)pyrrol-2-one for use in the treatment of gram-negative bacterial infections, in particular infections in which Pseudomonas is implicated.

公开(公告)号：US11083706B2

公开(公告)日：2021-08-10

申请号：US16316952

申请日：2017-07-13

Applicant: Conopco, Inc.

Inventor： Neil James Parry ,  Paolo Pantalone ,  Paul Williams

IPC: A61K31/4015 ,  A61P17/02 ,  A61P31/04 ,  A61K9/06 ,  A61K31/40 ,  A61K31/402

Abstract: Lactams for use in the treatment of skin lesions are described. In particular, lactams for the treatment of chronic wounds, including chronic wounds in patients having diabetes.